In Brief This Week: Life Technologies, FTC; Abbott; Saladax; PerkinElmer; Vermillion; More | GenomeWeb

NEW YORK (GenomeWeb News) – Life Technologies said late last week in a regulatory filing that it has received a second request from the US Federal Trade Commission for more information about its pending $13.6 billion sale to Thermo Fisher Scientific. The company said it is cooperating with FTC and continues to expect the acquisition to close in early 2014.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: diatom genetic diversity, microfluidic droplet method for single-cell screening, and more.

Scientific publishers are looking into whether artificial intelligence can help the peer-review process, Wired reports.

Researchers are using gene editing to develop more robust livestock and crops, AFP reports.

Researchers rally near the American Association for the Advancement of Science annual meeting in Boston.